Navigation Links
Researchers Investigate Protein that Protects Tumors

A protein that allows breast cancer cells to evade the body’s natural immune responses could be a target of future cancer therapies//, according to a study by Keck School of Medicine of USC scientists published today.

The study, published in the July 1 issue of the American Journal of Pathology, is the first to identify how EphB4 – a protein that sits on the surface of cells – functions.

“The important aspect of this study is that … if we turn the protein [EphB4] off, the tumor cells die, which means that its function helps the cancer cells survive,” says Parkash S. Gill, MD, a professor of medicine in the Keck School the study’s senior author.

The scientists used a fluorescent dye attached to the protein’s antibody to reveal the protein’s location on the tumor cells.

“The first step was to identify whether it’s there [on cancer cells] and how often,” he explained. “We found that it was present on 60 percent of the tumors … and it’s expressed from the very first stage of the cancer formation.”

The next step was to determine EphB4’s purpose. What the scientists discovered was that EphB4 serves as a sentry, guarding the tumor cells from any defenses the body deploys to attack them.

“There are means in the body to kill tumor cells,” Gill says. “[If] you block those then you give the cells the opportunity to survive and grow.” Not only did EphB4 block those defenses, but it helped the cancer cells flourish by issuing a call for more blood vessels – the biological equivalent of food for the tumor.

“The tumor cell carrying this protein … on its surface communicates with blood vessels nearby,” Gill says. “It sends the signal for more blood vessels to grow. One key item for any cancer to grow is to include more blood vessels.”

The goal of a future anti-cancer therapy would be to block the protein, essentially knocking out one of the tumor cell’s guardians. A similar approach was used to develop Herceptin, one of the first biological treatments for breast cancer. Herceptin targets the her2 protein, which is found on the surface of tumor cells about 20 percent of the time, says Gill.

The her2 protein played a role in this study as well. That protein, along with several of its cousins, was found to activate EphB4, he said. “There are certain growth factors that can make this particular protein (EphB4) go up,” Gill says. “We are learning more about how this protein is turned on and off in a cancer cell.”
(Source: Newswise)

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced ... User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics ... software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ...
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... the Commission on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its ... exclusive list of CAAHEP accredited colleges, as only one of twelve colleges and universities ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and ... of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. ... 5.10 up-to-date with a version of Asterisk that will receive not only security ...
(Date:11/26/2015)... VA (PRWEB) , ... November 26, 2015 , ... ... an American Express Travel Representative. As a franchise owner, Somu now offers travelers, ... of cruise, destination wedding packages, private cruise sales, as well as, cabin upgrades ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
Breaking Medicine Technology: